Adocia SA ADR (ADOCY)
Adocia SA ADR (OTC: ADOCY) is a depositary receipt representing common stock of Adocia SA, a clinical-stage biotechnology company focused on therapeutic solutions for diabetes and obesity. The company’s BioChaperone platform is designed to help deliver therapeutic proteins and underpins a portfolio of insulin- and peptide-based programs. Reported products and candidates include BioChaperone Lispro U100 and U200, BioChaperone Combo, BioChaperone LisPram, and M1Pram, along with preclinical programs such as AdoShell Islets, AdOral Sema, and AdoGel Sema. Adocia also has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. covering development and commercialization of BioChaperone Lispro in China and selected Asian and Middle Eastern markets. The company was incorporated in 2005 and is headquartered in Lyon, France.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Market Cap | Free Float / Shares Outstanding |
|---|---|---|---|---|---|---|
|
PINC-ADOCY
|
Not available
|
Not available
|
Not available
|
Weak
|
83.806 M
|
26.5%
|